This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
To learn more about the pharmacology of pravastatin by characterizing the dose-related effect and variability of the effect of pravastatin on the surrogate marker: low-density lipoprotein (LDL cholesterol). The effects of statins on morbidity and mortality is not the objective of this systematic review.
This is a protocol.